Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
Dr. Marie M. Zhu is currently CEO of MabPlex USA, Inc, a part of MabPlex International. Ltd, which offers one-stop CMO service for development and cGMP manufacturing for biologics including monoclonal antibodies (mAbs), antibody-drug conjugates (ADCs) and other recombinant proteins. Prior to joining MabPlex, Marie was Head of Process Sciences & Manufacturing at Agensys Inc, an Affiliate of Astellas Pharma Inc, with a focus on developing and producing biotherapeutics including mAbs and ADCs to treat prostate, bladder, pancreatic, ovarian, and kidney cancers. Marie has over 22 years of biotherapeutic development/manufacturing experience with contributions to numerous successful IND and BLA filings for a wide range of product types including small molecules, Fc fusion proteins, monoclonal mAbs, and ADCs with leading biotech and pharmaceutical companies: Pfizer, Bristol-Myers Squibb, Xencor, and Agensys/Astellas.
Marie received her B.S degree in Chemical Engineering from Tsinghua University, Beijing, China, and a Ph.D degree in Biochemical Engineering from University of Wisconsin-Madison, Wisconsin, USA.